MBS item 69471 · Category 6
Test of cell‑mediated immune response in blood for the detection of latent tuberculosis by interferon gamma release assay (IGRA) in the following people: (a) a person who has been exposed to a confirmed case of active tuberculosis; (b) a person who is infected with human immunodeficiency virus; (c) a person who is to commence, or has commenced, tumour necrosis factor (TNF) inhibitor therapy; (d) a person who is to commence, or has commenced, renal dialysis; (e) a person with silicosis; (f) a person who is, or is about to become, immunosuppressed because of a disease, or a medical treatment, not mentioned in paragraphs (a) to (e)
Schedule fee$34.90
75% benefit$26.20
85% benefit$29.70
100% benefit—
EMSN capN
Start date1998-11-01
The MBS benefit fields describe Medicare schedule settings. The provider's actual fee, private health insurance arrangements, hospital charges and other clinicians can change the amount you pay.
Classification
Where the item sits in the MBS
Category: 6
Group: P3
Subgroup: —
Subheading: —